ADCT
Price
$3.50
Change
+$0.09 (+2.65%)
Updated
Sep 5, 11:05 AM (EDT)
Capitalization
382.5M
67 days until earnings call
QNCX
Price
$1.58
Change
-$0.03 (-1.86%)
Updated
Sep 5, 11:31 AM (EDT)
Capitalization
86.21M
69 days until earnings call
Interact to see
Advertisement

ADCT vs QNCX

Header iconADCT vs QNCX Comparison
Open Charts ADCT vs QNCXBanner chart's image
ADC Therapeutics SA
Price$3.50
Change+$0.09 (+2.65%)
Volume$200
Capitalization382.5M
Quince Therapeutics
Price$1.58
Change-$0.03 (-1.86%)
Volume$100
Capitalization86.21M
ADCT vs QNCX Comparison Chart in %
Loading...
ADCT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
QNCX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ADCT vs. QNCX commentary
Sep 05, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ADCT is a StrongBuy and QNCX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 05, 2025
Stock price -- (ADCT: $3.40 vs. QNCX: $1.61)
Brand notoriety: ADCT and QNCX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ADCT: 144% vs. QNCX: 67%
Market capitalization -- ADCT: $382.5M vs. QNCX: $86.21M
ADCT [@Biotechnology] is valued at $382.5M. QNCX’s [@Biotechnology] market capitalization is $86.21M. The market cap for tickers in the [@Biotechnology] industry ranges from $101.77B to $0. The average market capitalization across the [@Biotechnology] industry is $1.88B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ADCT’s FA Score shows that 1 FA rating(s) are green whileQNCX’s FA Score has 0 green FA rating(s).

  • ADCT’s FA Score: 1 green, 4 red.
  • QNCX’s FA Score: 0 green, 5 red.
According to our system of comparison, ADCT is a better buy in the long-term than QNCX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ADCT’s TA Score shows that 5 TA indicator(s) are bullish while QNCX’s TA Score has 2 bullish TA indicator(s).

  • ADCT’s TA Score: 5 bullish, 3 bearish.
  • QNCX’s TA Score: 2 bullish, 5 bearish.
According to our system of comparison, ADCT is a better buy in the short-term than QNCX.

Price Growth

ADCT (@Biotechnology) experienced а +4.62% price change this week, while QNCX (@Biotechnology) price change was +4.22% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.78%. For the same industry, the average monthly price growth was +8.12%, and the average quarterly price growth was +29.45%.

Reported Earning Dates

ADCT is expected to report earnings on Nov 11, 2025.

QNCX is expected to report earnings on Nov 13, 2025.

Industries' Descriptions

@Biotechnology (+0.78% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ADCT($382M) has a higher market cap than QNCX($86.2M). ADCT YTD gains are higher at: 70.854 vs. QNCX (-14.171). QNCX has higher annual earnings (EBITDA): -41.32M vs. ADCT (-115M). ADCT has more cash in the bank: 265M vs. QNCX (34.7M). QNCX has less debt than ADCT: QNCX (17.5M) vs ADCT (118M). ADCT has higher revenues than QNCX: ADCT (77.2M) vs QNCX (0).
ADCTQNCXADCT / QNCX
Capitalization382M86.2M443%
EBITDA-115M-41.32M278%
Gain YTD70.854-14.171-500%
P/E RatioN/AN/A-
Revenue77.2M0-
Total Cash265M34.7M764%
Total Debt118M17.5M674%
FUNDAMENTALS RATINGS
QNCX: Fundamental Ratings
QNCX
OUTLOOK RATING
1..100
71
VALUATION
overvalued / fair valued / undervalued
1..100
52
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
40
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
49

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ADCTQNCX
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bearish Trend 1 day ago
89%
Bullish Trend 1 day ago
82%
Momentum
ODDS (%)
Bullish Trend 1 day ago
87%
Bearish Trend 1 day ago
87%
MACD
ODDS (%)
Bullish Trend 1 day ago
88%
N/A
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
80%
Bullish Trend 1 day ago
83%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
74%
Bearish Trend 1 day ago
90%
Advances
ODDS (%)
Bullish Trend 1 day ago
78%
N/A
Declines
ODDS (%)
N/A
Bearish Trend 9 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
88%
N/A
Aroon
ODDS (%)
Bearish Trend 1 day ago
88%
Bearish Trend 1 day ago
88%
View a ticker or compare two or three
Interact to see
Advertisement
ADCT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
QNCX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
RHHBF363.1014.00
+4.01%
Roche Holding Ltd
FBPI10.650.05
+0.47%
First Bancorp of Indiana, Inc.
ARSUF20.03N/A
N/A
Fagron SA
FRACF1.38N/A
N/A
Foraco International, Marseille
PNAGF5.00N/A
N/A
Petronas Gas Berhad

ADCT and

Correlation & Price change

A.I.dvisor indicates that over the last year, ADCT has been loosely correlated with QTTB. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if ADCT jumps, then QTTB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ADCT
1D Price
Change %
ADCT100%
+3.34%
QTTB - ADCT
47%
Loosely correlated
-2.92%
VTYX - ADCT
44%
Loosely correlated
+0.78%
CLRB - ADCT
42%
Loosely correlated
+4.18%
RGNX - ADCT
40%
Loosely correlated
-4.46%
OCUL - ADCT
39%
Loosely correlated
-1.85%
More

QNCX and

Correlation & Price change

A.I.dvisor indicates that over the last year, QNCX has been loosely correlated with MNPR. These tickers have moved in lockstep 33% of the time. This A.I.-generated data suggests there is some statistical probability that if QNCX jumps, then MNPR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To QNCX
1D Price
Change %
QNCX100%
-0.31%
MNPR - QNCX
33%
Loosely correlated
+7.26%
CCCC - QNCX
33%
Poorly correlated
+4.30%
ADCT - QNCX
31%
Poorly correlated
+3.34%
CLNN - QNCX
29%
Poorly correlated
+6.44%
KOD - QNCX
28%
Poorly correlated
-0.23%
More